Form 4: Surgery Partners CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
David T. Doherty, CFO of Surgery Partners, Inc., sold 721 shares of common stock on March 14, 2024, to satisfy tax withholding obligations related to the vesting of restricted stock.
Summary
- On March 14, 2024, David T. Doherty, the Chief Financial Officer of Surgery Partners, Inc., sold 721 shares of the company's common stock.
- The sale was executed at a weighted average price of $28.59 per share.
- This transaction was conducted to cover the reporting person's tax withholding obligations associated with the vesting of restricted stock on March 11, 2024.
- Following the transaction, Doherty directly owns 95,719 shares of Surgery Partners, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an insider stock sale for tax purposes, which is a neutral event.
Industry Context
Form 4 filings are routine disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.
Stakeholder Impact
- The sale of shares by the CFO could have a minor impact on shareholders, potentially creating a slight downward pressure on the stock price due to increased supply.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Restricted stock vested, triggering tax obligations. |
| 03/14/2024 | Date of stock sale by David T. Doherty. |
| 03/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.